acetaminophen 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]

RxCUI
2118730
RxNorm name
acetaminophen 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]
Display name
APADAZ (Oral Pill)
Full name
acetaminophen 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]
Term type
SBD
Status
Active
Strength
325-4.08 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-14 08:21:16

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042019
Active start
042019
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
acetaminophen325 MG / 1 EACHacetaminophenacetaminophen
benzhydrocodone hydrochloride4.08 MG / 1 EACHbenzhydrocodonebenzhydrocodone

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
acetaminophen161
benzhydrocodone2001352

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRApadaz 4.08 MG / 325 MG Oral Tablet1NAMES
RxNorm Nameacetaminophen 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID0590d4e5-7107-4015-a6a8-deac14265aa21CODES
RxCUI21187301CODES
MMSL_CODEBD347571CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
70040-0145-170040-0145APADAZ Benzhydrocodone and AcetaminophenZevra Therapeutics, Inc.NDA208653

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA20865370040-0145APADAZ Benzhydrocodone and AcetaminophenNDAZevra Therapeutics, Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
10702034001rxnav_ndcsyes
70040014501rxnav_ndcsyes
70040014503rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
APADAZBENZHYDROCODONE AND ACETAMINOPHENZevra Therapeutics, Inc.0590d4e5-7107-4015-a6a8-deac14265aa22025-01-07Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70040-0145-1
ndc (product): 70040-0145
ndc11 (package): 70040014501
rxcui: 2118730

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0590d4e5-7107-4015-a6a8-deac14265aa2apadaz 4.08 MG / 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz] [SBD] · Apadaz 4.08 MG / 325 MG Oral Tablet [SY] · APAP 325 MG / benzhydrocodone 4.08 MG Oral Tablet [Apadaz] [SY]45These highlights do not include all the information needed to use APADAZ® safely and effectively. See full prescribing information for APADAZ. APADAZ (benzhydrocodone and acetaminophen) tablets, for oral use, CII Initial U.S. Approval: 198220250107

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
0590d4e5-7107-4015-a6a8-deac14265aa2These highlights do not include all the information needed to use APADAZ® safely and effectively. See full prescribing information for APADAZ. APADAZ (benzhydrocodone and acetaminophen) tablets, for oral use, CII Initial U.S. Approval: 1982Zevra Therapeutics, Inc. | KVK-Tech, Inc. | Veranova, L.P. | SpecGx LLC | Patheon Pharmaceuticals, Inc. | Sharp Packaging Services, LLC20250107
3a790a49-df42-4577-914c-6ee07a40b60fThese highlights do not include all the information needed to use APADAZ® safely and effectively. See full prescribing information for APADAZ. APADAZ (benzhydrocodone and acetaminophen) tablets, for oral use, CII Initial U.S. Approval: 1982KVK-Tech, Inc.20210312

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD001249AsthmaDISEASEci_withbenzhydrocodone
MEDRTD003863DepressionDISEASEci_withbenzhydrocodone
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzhydrocodone
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD007415Intestinal ObstructionDISEASEci_withbenzhydrocodone
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010146PainDISEASEmay_treatbenzhydrocodone
MEDRTN0000191866Opioid mu-Receptor AgonistsMOAhas_moabenzhydrocodone
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000175439AnalgesiaPEhas_pebenzhydrocodone
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH325 MG / 4.08 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE2
CODESNDANDA208653
NAMESPrescribable Synonymapadaz 4.08 MG / 325 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon